Eclampsia or Epilepsy Pre eclampsia Eclampsia and HELLP syndrome
Document Sample


Eclampsia or Epilepsy?
Dr. F. Moses
Is There A Difference?
• De Sauvages (1739) differentiated eclampsia from
epilepsy in his Pathologia Methodica.
• He indicated that epilepsy is chronic and that the
fits recur over long periods of time.
• All convulsions of acute causation De Sauvages
called eclampsia.
A Safe Assumption
• Seizures in a pregnant patient beyond 20 weeks
are generally assumed to be eclampsia until
proven otherwise.
• Other possible causes include epilepsy.
• Amniotic fluid embolism is very rare but
seizures can be a presenting symptom (with
absence of proteinuria).
The History, The BP, The Urine
• History, physical examination (chiefly BP) and
urinary protein determination are key.
• Patient may be known to have epilepsy or
previous seizures.
• Diagnosis is based on history. Previous EEG may
show characteristic pattern.
• Absence of proteinuria also suggests epilepsy.
Pre-Eclampsia
Definition:
A disorder associated with pregnancy consisting
of
• Hypertension
• Proteinuria and
• New-onset dependent oedema
most commonly after 20 weeks of gestation
Eclampsia
Definition:
Pre-eclampsia complicated with seizures.
Diagnosis
• Hypertension
▫ Systolic > 140mmHg or 30mmHg above
pre-pregnancy level
▫ diastolic > 90 mmHg or 15mmHg above
pre-pregnancy level
• Two abnormal measurements, on two occasions,
more than 6 hours apart
Aetiology
• Exact pathophysiology unknown
• It occurs only in the presence of a placenta and is
resolved by its removal
• Possible causes:
▫ placental hypoperfusion
▫ increased sensitivity of the maternal vasculature to
pressure agents leading to vasospasm and
hypoperfusion of multiple organs
▫ an activation of the coagulation cascade leads to
microthrombi formation and aggravates the
perfusion problem
Pathophysiology
• Loss of plasma from the vascular tree with the
resulting oedema additionally compromises the
situation.
• These events lead to signs and symptoms of
toxaemia including hypertension, renal,
pulmonary, and hepatic dysfunction, and - in
eclampsia specifically - cerebral dysfunction.
• Preclinical markers of the disease process are
signs of increased platelet and endothelial
activation
Signs and symptoms
• Typically patients show signs of PIH and
proteinuria prior to the eclamptic convulsion.
• Other cerebral signs may precede the convulsion
such as
Nausea
Vomiting
Headaches
Cortical blindness.
Signs and symptoms
• With the advancement of the pathophysiological
process, other organ symptoms may be present
including
abdominal pain
liver failure
pulmonary oedema, and
Oliguria
• The foetus may have been already compromised
by IUGR, and may suffer foetal distress.
• Placental bleeding and placental abruption may
occur
Risk Factors
• Low socioeconomic class
• Multiple foetuses, or hydatid
• Maternal age <20 or >35yrs
• Primip
• Gestational or pre-gestational DM
• Renal disease
• Afro Caribbean- twice as likely
• Family history- 4x the risk
The eclamptic seizure
• L. C. Chesley distinguishes these four stages of an
eclamptic event:
▫ Stage of invasion: facial twitching can be observed around
the mouth.
▫ Stage of contraction: tonic contractions render the body
rigid; this stage may last about 15 to 20 seconds.
▫ Stage of convulsion: involuntary and forceful muscular
movements occur, the tongue may be bitten, foam appears
at the mouth. The patient stops breathing and becomes
cyanotic; this stage lasts about one minute.
▫ Prolonged coma: the final stage. When the patient
awakens, she is unlikely to remember the event. In some
rare cases there are no convulsions and the patient falls
directly into a coma. Some patients when they awake from
the coma may have temporary blindness.
• During a seizure, the foetus may experience bradycardia
Investigation
• Hypertension
• Urinalysis- proteinuria greater than 2+
• Blood tests
• CT head
• Foetal USS
Treatment
• Treatment of eclampsia requires prompt
intervention and aims to prevent further
convulsions, control the elevated blood pressure
and deliver the foetus.
• Prevention of convulsions is by using
magnesium sulphate.
• The serum Mg2+ therapeutic range for the
prevention of the eclamptic uterine contractions
is 4.0-7.0 mEq/L.
Treatment
• Serum Mg2+ concentrations associated with
maternal toxicity (also neonate depression or
hypotonia and low Apgar scores) are:
▫ 7.0–10.0 mEq/L - loss of patellar reflex
▫ 10.0–13.0 mEq/L - respiratory depression
▫ 15.0–25.0 mEq/L - altered atrio-ventricular
conduction and (further) complete heart block
▫ >25.0 mEq/L - cardiac arrest
MgSO4 Regimen
As described by Pritchard & colleagues:
• Loading dose of 4 gm IV (20%solution) over 5 min
minimum (preferably 10-15 min) followed
immediately by 5gm in a 50% solution as a deep
I/M injection into the upper outer quadrant of each
buttock.
• Maintenance dose is a further 5 gm IM every 4 hrs,
continued for 24 hours after the last fit.
Complications/prognosis
• Permanent brain damage
• Renal insufficiency
• Abruption
• Death
• 25% of eclamptics will be so in future
pregnancies
• Increased risk of essential hypertension
• Epileptic seizures from brain damage
HELLP syndrome
• Undiagnosed pre-eclampsia progresses to cause-
Haemolysis
Elevated Liver enzymes
Low Platelets
• May also occur de novo
HELLP 2
• Incidence- 0.1-0.6% of pregnancies
4-12% of pre-eclampsia
• Similar to pre-eclampsia with
▫ RUQ/epigastric pain
▫ Jaundice
▫ Microangiopathic anaemia
▫ Deranged LFT’s
• Treatment- ABC, O&G, admit, deliver
HELLP syndrome
• Microangiopathic hemolytic anemia, consumptive
thrombocytopenia, liver dysfunction
• 4-12% of patients with severe preeclampsia, 30% occur
postpartum
• DIC often secondary to placental abruption, sepsis or fetal
death
• Platelet count indirectly proportional to severity of disease
• Differential diagnoses: TTP, HUS, SLE, sepsis, acute fatty
liver of pregnancy
• Complications: ARF, ARDS, hemorrhage, placental
abruption, rarely liver hematoma with rupture
Get documents about "